Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients (SMILE™)

What is the purpose of this trial?

Multi center, randomized controlled study, to determine if a significant decrease in the rate of heart failure re-hospitalizations occurs during a follow-up period when - ReDS guided treatment is used as an adjunct to standard of care.


Participation Guidelines

Ages: 21 years and older

Gender: Both


Sensible Medical Innovations

Dates: 03/10/2016 - 09/30/2017

Last Updated: 03/11/2016

Study HIC#: 1510016594

Get Involved

For more information about this study, contact:
Douglas W Heller
203-737-3570
douglas.heller@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image